Working… Menu

WREX Outcome Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02218593
Recruitment Status : Unknown
Verified August 2014 by Tariq Rahman, Nemours Children's Clinic.
Recruitment status was:  Enrolling by invitation
First Posted : August 18, 2014
Last Update Posted : August 18, 2014
Information provided by (Responsible Party):
Tariq Rahman, Nemours Children's Clinic

Brief Summary:
This study is to evaluate how the Wilmington Robotic Exoskeleton (WREX) is working for children who are using the WREX, or have used it in the past. The survey consists of a set of questions a) performed online and b) performed over the phone.

Condition or disease Intervention/treatment Phase
Muscular Dystrophy Arthrogryposis Spinal Muscular Atrophy Device: WREX orthosis Not Applicable

Detailed Description:
The WREX (Wilmington Robotic EXoskeleton) is being used by many children with neuromuscular conditions such as arthrogryposis and muscular dystrophy. Nemours/A.I. duPont Hospital for Children alone has provided a WREX for about 80 children in the last 3 years. This is being done through the orthopedic and muscle clinics in the hospital. We would like to perform a retrospective study to see how well the children are doing with the WREX. We propose getting this feedback through a survey administered to families using the WREX. The survey will be performed in two parts. 1) A phone survey will use the Canadian Occupational Performance Measure (COPM). 2) an online survey with additional questions. The parents are asked to submit answers on behalf of the children if they are unable to.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 42 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Official Title: WREX Outcome Study
Study Start Date : July 2014
Estimated Primary Completion Date : October 2014
Estimated Study Completion Date : July 2015

Arm Intervention/treatment
Experimental: WREX orthosis
WREX Orthosis
Device: WREX orthosis
Upper extremity exoskleton used to assist movement

Primary Outcome Measures :
  1. Activities of daily living [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Neuromuscular disease
  • Use the Wilmington Robotic Exoskeleton

Exclusion Criteria:

  • people who do not use the Wilmington Robotic Exoskeleton
Layout table for additonal information
Responsible Party: Tariq Rahman, Prinicipal Research Engineer, Nemours Children's Clinic Identifier: NCT02218593    
Other Study ID Numbers: 579772-2
First Posted: August 18, 2014    Key Record Dates
Last Update Posted: August 18, 2014
Last Verified: August 2014
Additional relevant MeSH terms:
Layout table for MeSH terms
Muscular Dystrophies
Muscular Atrophy
Muscular Atrophy, Spinal
Pathological Conditions, Anatomical
Muscular Disorders, Atrophic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Genetic Diseases, Inborn
Neuromuscular Manifestations
Neurologic Manifestations
Spinal Cord Diseases
Central Nervous System Diseases
Motor Neuron Disease
Neurodegenerative Diseases
Joint Diseases
Musculoskeletal Abnormalities
Congenital Abnormalities